Chad M Robins's Net Worth

$51.5 Million

Estimate Recalculated May 20, 2025 11:47PM EST

Who is Chad M Robins

Chad M Robins has an estimated net worth of $51.5 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, CM Life Sciences III Inc., and ARYA Sciences Acquisition Corp II.

SEC CIK

Chad M Robins's CIK is 0001780649

Past Insider Trading and Trends

2020 was Chad M Robins's most active year for acquiring shares with 42 total transactions. Chad M Robins's most active month to acquire stocks was the month of February. 2020 was Chad M Robins's most active year for disposing of shares, totalling 114 transactions. Chad M Robins's most active month to dispose stocks was the month of February. 2020 saw Chad M Robins paying a total of $617,272.15 for 1,089,505 shares, this is the most they've acquired in one year. In 2020 Chad M Robins cashed out on 1,650,495 shares for a total of $32,042,045.09, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptive Biotechnologies Corp

CEO and Chairman
Updated Mar 06, 2024
Form 4
13.47%
305.94K
$3.43
-$167.01K
Mar 06, 2024
2.58M
Grant
Mar 04 - Mar 05
Form 4
18.51%
354.61K
Mar 08, 2023
2.27M
Grant
Mar 06
Form 4
-3.82%
-103.70K
$7.97
-$617.98K
Mar 09, 2022
2.67M
Sale
ScheduledMar 07 - Mar 09
Form 4
14.50%
242.69K
$12.01
-$53.13K
Mar 08, 2022
1.92M
Grant
Mar 04 - Mar 07
Form 4
-2.53%
-43.50K
$38.43
-$1.67M
Sep 10, 2021
1.67M
Sale
ScheduledSep 08 - Sep 10
Form 4
-0.09%
-1.50K
$38.24
-$57.40K
Jul 14, 2021
1.72M
Sale
ScheduledJul 12
Form 4
-1.72%
-30.00K
$38.47
-$1.15M
Jun 17, 2021
1.72M
Sale
ScheduledJun 15 - Jun 17
Form 4
-0.85%
-15.00K
$41.81
-$627.11K
Apr 08, 2021
1.75M
Sale
ScheduledApr 06 - Apr 08
Form 4
-0.84%
-15.00K
$42.89
-$643.42K
Mar 19, 2021
1.76M
Sale
ScheduledMar 17 - Mar 19
Form 4
14.06%
240.38K
Mar 08, 2021
1.95M
Grant
Mar 04
Form 4
-1.72%
-30.00K
$62.31
-$1.87M
Feb 10, 2021
1.71M
Sale
ScheduledFeb 08 - Feb 10
Form 4
-1.70%
-30.00K
$59.38
-$1.78M
Jan 28, 2021
1.74M
Sale
ScheduledJan 26 - Jan 28
Form 4
-0.47%
-8.40K
$70.43
-$591.60K
Jan 21, 2021
1.77M
Sale
ScheduledJan 19
Form 4
-2.71%
-49.56K
$30.11
-$2.95M
Dec 30, 2020
1.78M
Sale
ScheduledDec 28 - Dec 30
Form 4
-2.66%
-50.04K
$23.66
-$2.33M
Nov 19, 2020
1.83M
Sale
ScheduledNov 17 - Nov 19
Form 4
-4.70%
-92.54K
$25.23
-$4.61M
Oct 08, 2020
1.88M
Sale
ScheduledOct 06 - Oct 08
Form 4
-0.13%
-2.50K
$25.24
-$124.55K
Oct 01, 2020
1.97M
Sale
ScheduledSep 29 - Oct 01
Form 4
-0.90%
-50.04K
$23.11
-$2.27M
Sep 18, 2020
5.50M
Sale
ScheduledSep 16 - Sep 18
Form 4
-1.55%
-32.03K
$21.78
-$1.17M
Aug 12, 2020
2.02M
Sale
ScheduledAug 10 - Aug 12
Form 4
-2.54%
-54.03K
$19.04
-$2.02M
Jul 31, 2020
2.07M
Sale
ScheduledJul 29 - Jul 31
Form 4
-1.53%
-33.13K
$23.09
-$1.51M
Jun 23, 2020
2.13M
Sale
ScheduledJun 22
Form 4
-3.13%
-69.68K
$22.45
-$3.08M
Jun 19, 2020
2.16M
Sale
ScheduledJun 17 - Jun 19
Form 4
-10.08%
-250.00K
$20.28
-$5.98M
May 21, 2020
2.23M
Sale
ScheduledMay 19 - May 21
Form 4
-1.78%
-45.00K
$17.97
-$1.59M
May 08, 2020
3.33M
Sale
ScheduledMay 07
Form 4
-1.90%
-49.04K
$14.30
-$1.36M
Apr 15, 2020
3.37M
Sale
ScheduledApr 13 - Apr 15
Form 4
-0.64%
-16.68K
$11.42
-$369.73K
Mar 23, 2020
3.42M
Sale
ScheduledMar 19 - Mar 20
Form 4
11.10%
288.88K
$15.94
-$347.28K
Feb 18, 2020
3.74M
Sell-Options
ScheduledFeb 13
Form 4
-0.66%
-22.24K
$15.78
-$687.44K
Feb 12, 2020
4.19M
Sale
ScheduledFeb 11 - Feb 12
Form 4
-0.80%
-33.36K
$15.52
-$1.01M
Jan 29, 2020
5.00M
Sale
ScheduledJan 27 - Jan 29
Form 4
$0.33
$6.60K
Oct 25, 2019
5.75M
Options
Oct 23
Form 4
Jul 03, 2019
4.95M
Options
Jul 01
Form 3
Jun 26, 2019
4.88M
Showing 32 results

CM Life Sciences III Inc.

Investor
Updated Apr 06, 2021
Form 3
Apr 06, 2021
Showing 1 results

ARYA Sciences Acquisition Corp II

Investor
Updated Jun 04, 2020
Form 3
Jun 04, 2020
Showing 1 results